Evidence map›Paper›PMID 42816717›Full record

ArticleCEN case reports2026

When two rare diseases meet: atypical hemolytic uremic syndrome and alkaptonuria in two siblings.

Cebrail Karaca, Beril Karatas, Ruhat Tunc, Mehmet Erdem, Mevlut Tamer Dincer, Safak Mirioglu

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cebrail KaracaDivision of Nephrology, Department of Internal Medicine, Faculty of Medicine, Van Yuzuncu Yil University, Bardakçı, Yüzüncü Yıl Üniversitesi Kampüsü, 65090, Tuşba, Van, Turkey. cebrailkaraca@gmail.com.ORCID 0000-0003-0969-7708
Beril KaratasDivision of Nephrology, Department of Internal Medicine, Faculty of Medicine, Van Yuzuncu Yil University, Bardakçı, Yüzüncü Yıl Üniversitesi Kampüsü, 65090, Tuşba, Van, Turkey.
Ruhat TuncDepartment of Internal Medicine, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
Mehmet ErdemDepartment of Internal Medicine, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
Mevlut Tamer DincerDivision of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Safak MiriogluDivision of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated thrombotic microangiopathy (TMA), whereas alkaptonuria (AKU) is an uncommon inherited metabolic disorder. Their coexistence has not previously been described. We report two siblings from a consanguineous family with CD46-associated aHUS and AKU to highlight an unusual diagnostic challenge and the importance of recognizing coexisting inherited diseases. Two brothers experienced recurrent episodes of TMA characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, while maintaining preserved long-term renal function despite persistent proteinuria. Genetic analysis identified a homozygous CD46 variant consistent with familial aHUS. During evaluation, recurrent black discoloration of urine, chronic back and knee pain, scleral pigmentation, and a history of black-stained diapers since infancy suggested an additional inherited disorder. Subsequent testing confirmed a homozygous pathogenic HGD variant, establishing the diagnosis of AKU. Both patients achieved hematologic remission following complement inhibition and remained free of dialysis throughout follow-up. To our knowledge, this is the first report of the coexistence of aHUS and AKU. These cases demonstrate that persistent or recurrent black discoloration of urine in patients with TMA should not be assumed to result solely from hemolysis. Careful assessment of atypical clinical features, supported by genetic testing when appropriate, may facilitate recognition of coexisting inherited disorders, particularly in consanguineous families, and improve diagnostic accuracy and long-term patient management.

Indexed as

AlkaptonuriaAtypical Hemolytic Uremic SyndromeConsanguinityHomozygoteHumansMaleMembrane Cofactor ProteinPedigreeSiblingsThrombotic MicroangiopathiesCD46 protein, humanMembrane Cofactor ProteinAlkaptonuriaAtypical hemolytic uremic syndromeCD46ConsanguinityThrombotic microangiopathyUrine discoloration

Identifiers

PMID42816717
PMCPMC13627559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.